Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 3
1963 2
1964 4
1965 2
1969 1
1971 1
1972 1
1974 2
1975 7
1976 2
1977 3
1978 1
1979 11
1980 4
1981 1
1983 3
1984 3
1986 1
1987 1
1988 1
1991 2
1992 2
1993 2
1997 1
1998 2
2000 4
2002 3
2003 5
2005 2
2007 1
2008 3
2009 1
2010 3
2011 3
2012 4
2013 7
2014 6
2015 7
2016 9
2017 9
2018 17
2019 14
2020 12
2021 12
2022 13
2023 12
2024 10
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
[Initial Medical Care for Spinal Injury].
Sasada S, Kin K, Yasuhara T. Sasada S, et al. Among authors: kin k. No Shinkei Geka. 2023 Nov;51(6):1051-1061. doi: 10.11477/mf.1436204851. No Shinkei Geka. 2023. PMID: 38011879 Japanese.
Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial.
Paton NI, Gurumurthy M, Lu Q, Leek F, Kwan P, Koh HWL, Molton J, Mortera L, Naval S, Bakar ZA, Pang YK, Lum L, Lim TK, Cross GB, Lekurwale G, Choi H, Au V, Connolly J, Hibberd M, Green JA; Pascolizumab Tuberculosis Trial Team. Paton NI, et al. J Infect Dis. 2024 Sep 23;230(3):590-597. doi: 10.1093/infdis/jiae104. J Infect Dis. 2024. PMID: 38527849 Clinical Trial.
Cell therapy for central nervous system disorders: Current obstacles to progress.
Yasuhara T, Kawauchi S, Kin K, Morimoto J, Kameda M, Sasaki T, Bonsack B, Kingsbury C, Tajiri N, Borlongan CV, Date I. Yasuhara T, et al. Among authors: kin k. CNS Neurosci Ther. 2020 Jun;26(6):595-602. doi: 10.1111/cns.13247. Epub 2019 Oct 17. CNS Neurosci Ther. 2020. PMID: 31622035 Free PMC article. Review.
202 results